The cardiovascular community has witnessed an important transition over the past two decades—from awareness of the global nature of the cardiovascular disease epidemic, to identification of interventions to control it, and now to a resolution that global action is urgently required.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
The World Bank. World Development Report 1993: Investing in Health (Oxford University Press, Oxford, 1993).
Institute of Medicine. Control of Cardiovascular Disease in Developing Countries: Research, Development, and Institutional Strengthening (eds Howson, C. P., Reddy, K. S., Ryan, T. J. & Bale, J. R.) (National Academy Press, Washington DC, 1998).
Lopez, A. D., Mathers, C. D., Ezzati, M., Jamison, D. T. & Murray, C. J. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367, 1747–1757 (2006).
Yusuf, S. et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study. Lancet 364, 937–952 (2004).
Wilson, P. W. et al. Prediction of coronary heart disease using risk factor categories. Circulation 97, 1837–1847 (1998).
Leeder, S., Raymond, S. & Greenberg, H. A Race Against Time: The Challenge of Cardiovascular Disease in Developing Economies (Trustees of Columbia University, New York, 2004).
WHO. Preventing Chronic Diseases: A Vital Investment: WHO Global Report (WHO, Geneva, 2005).
Beaglehole, R., Ebrahim, S., Reddy, S., VoÛte, J. & Leeder, S. for the Chronic Disease Action Group. Prevention of chronic diseases: a call to action. Lancet 370, 2152–2157 (2007).
Daar, A. S. et al. Grand challenges in chronic non-communicable diseases. Nature 450, 494–496 (2007).
Asaria, P., Chisholm, D., Mathers, C., Ezzati, M. & Beaglehole, R. Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use. Lancet 370, 2044–2053 (2007).
Gaziano, T. A. Economic burden and the cost-effectiveness of treatment of cardiovascular diseases in Africa. Heart 94, 140–144 (2008).
Gaziano, T. A., Opie, L. H. & Weinstein, M. C. Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis. Lancet 368, 679–686 (2006).
Lim, S. S. et al. Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs. Lancet 370, 2054–2062 (2007).
Smith, S. C. Jr et al. Principles for national and regional guidelines on cardiovascular disease prevention: a scientific statement from the World Heart and Stroke Forum. Circulation 109, 3112–3121 (2004).
Grundy, S. M. et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110, 227–239 (2004).
[No authors listed.] Sesame Workshop. World Heart Federation [online], http://www.world-heart-federation.org/what-we-do/children-youth/sesame-workshop/ (2009).
Acknowledgements
This article has been reviewed and approved by the institute of Medicine Committee on Preventing the Global epidemic of Cardiovascular Disease: Meeting the Challenges in Developing Countries.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Vedanthan, R., Fuster, V. The moving target of global cardiovascular health. Nat Rev Cardiol 6, 327–328 (2009). https://doi.org/10.1038/nrcardio.2009.48
Issue Date:
DOI: https://doi.org/10.1038/nrcardio.2009.48